| Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells A Sotthibundhu, K McDonagh, A von Kriegsheim, A Garcia-Munoz, ... Stem Cell Research & Therapy 7, 1-16, 2016 | 82 | 2016 |
| NRXN1 deletion syndrome; phenotypic and penetrance data from 34 families M Al Shehhi, EB Forman, JE Fitzgerald, V McInerney, J Krawczyk, S Shen, ... European journal of medical genetics 62 (3), 204-209, 2019 | 61 | 2019 |
| Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care LG Glynn, A Mustafa, M Casey, J Krawczyk, J Blom, R Galvin, A Hannigan, ... Pilot and feasibility studies 4, 1-7, 2018 | 54 | 2018 |
| AKT as a therapeutic target in multiple myeloma NA Keane, SV Glavey, J Krawczyk, M O’Dwyer Expert opinion on therapeutic targets 18 (8), 897-915, 2014 | 52 | 2014 |
| The role of inflammation in leukaemia. FJ Giles, J Krawczyk, M O'Dwyer, R Swords, C Freeman Advances in experimental medicine and biology 816, 335-360, 2014 | 39* | 2014 |
| Beyond DNA damage: exploring the immunomodulatory effects of cyclophosphamide in multiple myeloma D Swan, M Gurney, J Krawczyk, AE Ryan, M O’Dwyer Hemasphere 4 (2), e350, 2020 | 36 | 2020 |
| Increased Ca2+ signaling in NRXN1α+/− neurons derived from ASD induced pluripotent stem cells S Avazzadeh, K McDonagh, J Reilly, Y Wang, SD Boomkamp, ... Molecular Autism 10, 1-16, 2019 | 34 | 2019 |
| Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities SA Mohamed, L Howard, V McInerney, A Hayat, J Krawczyk, S Naughton, ... Cytotherapy 22 (6), 313-321, 2020 | 33 | 2020 |
| The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells DV Baev, J Krawczyk, E Szegezdi Leukemia research reports 3 (2), 79-82, 2014 | 30 | 2014 |
| CyBorD-DARA is potent initial induction for MM and enhances ADCP: initial results of the 16-BCNI-001/CTRIAL-IE 16-02 study M O’dwyer, R Henderson, SD Naicker, MR Cahill, P Murphy, V Mykytiv, ... Blood Advances 3 (12), 1815-1825, 2019 | 21 | 2019 |
| Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients A Szudy‐Szczyrek, R Mlak, M Bury‐Kamińska, M Mielnik, M Podgajna, ... British Journal of Haematology 191 (1), 77-89, 2020 | 19 | 2020 |
| Perifosine–a new option in treatment of acute myeloid leukemia? J Krawczyk, N Keane, R Swords, M O'Dwyer, CL Freeman, FJ Giles Expert opinion on investigational drugs 22 (10), 1315-1327, 2013 | 19 | 2013 |
| Chronic myeloid leukemia with e19a2 BCR-ABL1 transcripts and marked thrombocytosis: the role of molecular monitoring SE Langabeer, SL McCarron, J Kelly, J Krawczyk, S McPherson, K Perera, ... Case reports in hematology 2012, 2012 | 17 | 2012 |
| NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons S Avazzadeh, LR Quinlan, J Reilly, K McDonagh, A Jalali, Y Wang, ... BMC neuroscience 22, 1-14, 2021 | 16 | 2021 |
| New developments in the treatment of multiple myeloma–clinical utility of daratumumab C McEllistrim, J Krawczyk, ME O’Dwyer Biologics: Targets and Therapy, 31-43, 2017 | 15 | 2017 |
| The miR-17-92 cluster: Yin and Yang in human cancers W Zhao, A Gupta, J Krawczyk, S Gupta Cancer Treatment and Research Communications 33, 100647, 2022 | 14 | 2022 |
| A Novel High-Throughput Screening Platform Identifies Itaconate Derivatives from Marine Penicillium antarcticum as Inhibitors of Mesenchymal Stem Cell … P Marchese, N Mahajan, E O’Connell, H Fearnhead, M Tuohy, ... Marine Drugs 18 (4), 192, 2020 | 14 | 2020 |
| 5-Azacytidine for the treatment of myelodysplastic syndromes J Krawczyk, N Keane, CL Freeman, R Swords, M O'Dwyer, FJ Giles Expert opinion on pharmacotherapy 14 (9), 1255-1268, 2013 | 13 | 2013 |
| No prognostic impact of P2 RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia. J Krawczyk, K Haslam, P Lynam, J Kelly, L Storey, A O'Marcaigh, ... British journal of haematology 160 (4), 2013 | 13 | 2013 |
| Tc buster transposon engineered CLL-1 CAR-NK cells efficiently target acute myeloid leukemia M Gurney, E O'Reilly, S Corcoran, S Brophy, D Hardwicke, J Krawczyk, ... Blood 138, 1725, 2021 | 11 | 2021 |
Michael O'DwyerHaematologynuigalway.ie üzerinde doğrulanmış e-posta adresine sahip
